Pediatric Academic
Societies'
Annual Meeting

        HOME                                                                                                                                         SITE MAP  

Sponsoring Organizations
Click on the links below to visit individual websites
American Pediatric Society
Society for Pediatric Research
Ambulatory Pediatric Association

Alliance Organizations

Program Information

Program Committee & Contacts

Awards

Registration & Housing

Exhibits

Support and Partnerships

Future Meetings

Past Meetings

Pediatric Related Links

Contact Information

Mail Address:

Suite B-7
3400 Research Forest Drive

The Woodlands, TX  77381 USA

Telephone:  281-419-0052

Facsimile:  281-419-0082

Email:  info@pas-meeting.org

2002 Abstract Submission Deadline: 
December 6, 2001

Only abstracts submitted on OFFICIAL 2001 PAS electronic submission program or official abstract forms will be accepted. No other format of submission is permitted.

Publication of Abstracts

ALL abstracts submitted for consideration to the Meeting will be published in the 2001 Pediatric Research - Program/Proceedings (April issue). The Program/Proceedings will be issued to Pediatric Research subscribers. Other registrants can purchase the proceedings through registration for the PAS Annual Meeting, or by contacting the publisher.

GENERAL POLICIES

• Electronic Submission Deadline is December 6, 2000, 11:59 pm, Central Standard Time.

• All abstract must be sponsored (and signed) by a member of one of the sponsoring organizations for the 2001 Annual Meeting (APS, SPR, or APA) and submitted using the 2001 OFFICIAL electronic submission program or 2001 OFFICIAL abstract form. The sponsoring member must be in good standing (dues current) or the abstract will not be considered. The sponsor does not have to be author.

• Of special note: The American Society of Pediatric Hematology/Oncology will meet in conjunction with the PAS this year and all abstracts will be submitted through the PAS. Members of ASPH/O may sponsor abstracts when submitted to the following subspecialties: Hematology/Oncology, Neonatal Immunology and Hematology

• Abstracts submitted or presented to other societies or national meetings can be submitted for consideration for the 2001 PAS Annual Meeting.

• Research published in manuscript form prior to the submission of the abstract is not appropriate and should not be submitted. If data contained in the abstract is published after submission of the abstract, the Central Office must be notified regardless of timing as soon as publication is recognized. At that time a member of the program committee will make a determination concerning presentation.

• Historically, abstracts accepted for presentation are hypothesis-driven new work. Abstracts rarely accepted for presentation include single case reports, open label drug trials, highly speculative accounts of clinical experience, and accounts of personal experience. Interim results from an ongoing clinical trial will not be accepted for presentation unless the study has been prematurely closed for efficacy, lack of efficacy, or issues of safety. The submission of multiple, similar abstracts from the same investigator(s) or laboratory are strongly discouraged. The deadline for submission of abstracts is absolute.  The submission of abstracts without data because investigations or analyses are incomplete will be evaluated only on the basis of the information contained in the abstract.  Late submissions will not be accepted for consideration in regular program planning. 

• There is no limit on the number of abstracts submitted by each member, but the submission of multiple, similar abstracts from the same investigator(s) or laboratory is strongly discouraged.

• A fee of $40.00 is required for each abstract submitted.

• Conflict of Interest/Disclosure: Work submitted for presentation must include an acknowledgment of funding sources of commercial nature and/or consulting or holding of significant equity in a company that could be affected by the results of the study. Even if indicated elsewhere in the abstract, this must appear as the last sentence of the abstract and read "funded by..." and/or "equity in..." if pertinent.

• The submitting author must sign the abstract and attest that all authors have approved the submission of the work for presentation.

• Any animal studies must conform with the "Guiding Principles in the Care and Use of Animals" of the American Psychological Society and any human experimentation has been conducted according to a protocol approved by the institutional committee on ethics of human investigation. And, if no such committee exists, that it conforms with the principles of the Declaration of Helsinki of the World Medical Association (Clinical Research 14:193, 1966).

• If the abstract is selected, the presentation must include the methods used for study and any other information relevant to research.

• No changes are allowed after submission. Updates should be made at the time of presentation.

ABSTRACT SUBMISSION FEE

NOTIFICATION OF RECEIPT AND ACCEPTANCE

Notification of abstract acceptance status will be mailed after February 12, 2001. If you have not received notification by February 28, 2001, please contact the PAS Program Office at (281) 419-0052 or email (info@aps-spr.org)  for additional assistance.

IMPORTANT